SCMP
Sucampo Pharmaceuticals, Inc.
SCMP
SCMP
Delisted
SCMP was delisted on the 12th of February, 2018.
167 hedge funds and large institutions have $272M invested in Sucampo Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 68 increasing their positions, 46 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
167
Holders Change
–
Holders Change %
0%
% of All Funds
4.17%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
68
Reduced
46
Closed
23
Calls
$1.97M
Puts
$730K
Net Calls
+$1.24M
Net Calls Change
+$883K
Top Buyers
| 1 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$13.2M |
| 2 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$6.07M |
| 3 |
Citigroup
New York
|
+$3.23M |
| 4 |
BlackRock
New York
|
+$2.4M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.99M |
Top Sellers
| 1 |
RI
Redwood Investments
Boston,
Massachusetts
|
-$6.64M |
| 2 |
Millennium Management
New York
|
-$4.54M |
| 3 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.2M |
| 4 |
Renaissance Technologies
New York
|
-$3.16M |
| 5 |
CCMH
Cornerstone Capital Management Holdings
New York
|
-$2.79M |
